Table 1.
Detection rates for circulating tumor DNA (ctDNA)
Positive/Cases with somatic mutations |
|||
---|---|---|---|
ctDNA: PIK3CA and/or KRAS | ctDNA: PIK3CA | ctDNA: KRAS | |
Epithelial ovarian carcinoma | |||
Total | 23/85 (27.1) | 11/40 (27.5) | 12/48 (25.0) |
Stage I/II | 13/66 (19.7) | 7/32 (21.9) | 6/37 (16.2) |
Stage III/IV | 10/19 (52.6) | 4/8 (50.0) | 6/11 (54.5) |
Borderline tumor | 4/25 (16.0) | 0/2 (0.0) | 4/24 (16.7) |
Benign tumor | 0/4 (0.0) | - | 0/4 (0.0) |
Values are presented as number (%).